NDC product
Betoptic S
NDC 0078-0729 · Novartis Pharmaceuticals Corporation
Key facts
| Product NDC | 0078-0729 |
|---|---|
| Proprietary name | Betoptic S |
| Nonproprietary name | betaxolol hydrochloride |
| Substances | BETAXOLOL HYDROCHLORIDE |
| Dosage form | SUSPENSION/ DROPS |
| Route | OPHTHALMIC |
| Labeler | Novartis Pharmaceuticals Corporation |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA019845 |
| Pharmacologic classes | Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC] |
| Marketing start | Jan 15, 1996 |
| Marketing end | Nov 30, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory